← back to search

Monty Krieger

Massachusetts Institute of Technology · US
Area of research
Surgery · Cancer Research
Research interest
Research interests include Scavenger receptor, Chemistry, Receptor, Scavenger, Biology, and Myocardial infarction.
h-index
citations
751
works
9
NIH funding
primary concept
email

Recent publications

Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition
Circulation 2024cited by 48position: middledoi
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease
The Journal of Immunology 2017cited by 330position: middledoi
Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake
Bioorganic & Medicinal Chemistry Letters 2015cited by 20position: lastdoi
Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid Transport
ACS Medicinal Chemistry Letters 2015cited by 12position: lastdoi
Discovery of bisamide-heterocycles as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake
Bioorganic & Medicinal Chemistry Letters 2015cited by 9position: lastdoi
Standardizing Scavenger Receptor Nomenclature
The Journal of Immunology 2014cited by 200position: middledoi
Excess cholesterol induces mouse egg activation and may cause female infertility
Proceedings of the National Academy of Sciences 2014cited by 61position: lastdoi
Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
Proceedings of the National Academy of Sciences 2013cited by 56position: lastdoi
Noncanonical Role of the PDZ4 Domain of the Adaptor Protein PDZK1 in the Regulation of the Hepatic High Density Lipoprotein Receptor Scavenger Receptor Class B, Type I (SR-BI)
Journal of Biological Chemistry 2013cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Melissa Bennion · Biogen (United States)3 papers (2015–2015) · 3 papers (2015–2015)Stuart L. Schreiber · Harvard University3 papers (2015–2015)Chris Dockendorff · University of Wisconsin–Milwaukee3 papers (2015–2015)Thomas J.F. Nieland · Massachusetts Institute of Technology3 papers (2015–2015)Sivaraman Dandapani · NKT Therapeutics (United States)3 papers (2015–2015)José R. Perez · Universidad Nacional de Colombia3 papers (2015–2015)Michelle Palmer · Goethe University Frankfurt3 papers (2015–2015)Miao Yu · Beijing Proteome Research Center3 papers (2015–2015) · 3 papers (2015–2015) · 3 papers (2015–2015)Joachim Herz · Southwestern Medical Center2 papers (2014–2017)Dawn M. E. Bowdish · McMaster University2 papers (2014–2017)Lester Kobzik · Io Therapeutics (United States)2 papers (2014–2017)Mercy PrabhuDas · National Institute of Allergy and Infectious Diseases2 papers (2014–2017)Maria Febbraio · University of Alberta2 papers (2014–2017)Tatsuya Sawamura · Shinshu University2 papers (2014–2017)Olivier Kocher · Thomas Jefferson University2 papers (2013–2024)Søren K. Moestrup · University of Southern Denmark2 papers (2014–2017)Willmen Youngsaye · Takeda (United States)2 papers (2015–2015)